-0.05 (-1.32%)
Market Close As on 26 Sep, 2023, 03:35 PM
No data
Consensus EPS
Consensus Revenue
Sep 25
N/A N/A 10.95 M N/A
Sep 22
N/A N/A 10.95 M N/A
Sep 21
N/A N/A 10.95 M N/A
Sep 19
N/A N/A 10.95 M N/A
Sep 18
N/A N/A 10.95 M N/A
Sep 17
N/A N/A 10.95 M N/A

ALCJ.PA Profile

Industry: Medical Instruments & Supplies
Sector: Healthcare
CEO: Mr. Patrick Alexandre
Exchange: Euronext Paris

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.